We are live on ! Find out more
JIR

James Investment Research Portfolio holdings

AUM $984M
1-Year Est. Return 36.03%
This Fund
S&P 500
This Quarter Est. Return
+11.13%
1 Year Est. Return
+36.03%
3 Year Est. Return
+106.79%
5 Year Est. Return
+132.49%
10 Year Est. Return
+460.95%
AUM
$841M
AUM Growth
+$53.4M
Cap. Flow
-$9.63M
Cap. Flow %
-1.15%
Top 10 Hldgs %
27.4%
Holding
352
New
26
Increased
57
Reduced
124
Closed
14

Sector Composition

Rank Sector Weight
1 Technology 19.42%
2 Financials 14.08%
3 Consumer Discretionary 8.27%
4 Healthcare 6.17%
5 Communication Services 6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBTG icon
276
iShares iBonds Dec 2026 Term Treasury ETF
IBTG
$2.08B
$287K 0.03%
12,500
IBTK icon
277
iShares iBonds Dec 2030 Term Treasury ETF
IBTK
$1.02B
$285K 0.03%
14,350
HVT icon
278
Haverty Furniture Companies
HVT
$425M
$285K 0.03%
13,983
NUKZ icon
279
Range Nuclear Renaissance Index ETF
NUKZ
$790M
$282K 0.03%
+4,982
New +$229K
ELTK icon
280
Eltek
ELTK
$52.9M
$278K 0.03%
25,907
ACLS icon
281
Axcelis
ACLS
$3.72B
$277K 0.03%
+3,976
New +$227K
CCS icon
282
Century Communities
CCS
$1.97B
$269K 0.03%
4,769
ANIP icon
283
ANI Pharmaceuticals
ANIP
$1.71B
$266K 0.03%
4,075
HI
284
DELISTED
Hillenbrand
HI
$265K 0.03%
13,220
LPG icon
285
Dorian LPG
LPG
$2.05B
$261K 0.03%
10,707
ALKS icon
286
Alkermes
ALKS
$8.25B
$261K 0.03%
9,108
UE icon
287
Urban Edge Properties
UE
$2.71B
$258K 0.03%
13,811
BKU icon
288
Bankunited
BKU
$3.31B
$253K 0.03%
7,103
OSCR icon
289
Oscar Health
OSCR
$9.64B
$243K 0.03%
11,354
-3,772
-25% -$56.1K
NEM icon
290
Newmont
NEM
$139B
$241K 0.03%
+4,144
New +$221K
USIG icon
291
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.6B
$241K 0.03%
4,690
-65
-1% -$3.29K
CNR
292
Core Natural Resources Inc
CNR
$4.87B
$240K 0.03%
3,445
CWEN icon
293
Clearway Energy Class C
CWEN
$6.67B
$240K 0.03%
7,493
SNX icon
294
TD Synnex
SNX
$20.4B
$240K 0.03%
+1,765
New +$207K
RSPD icon
295
Invesco S&P 500 Equal Weight Consumer Discretionary ETF
RSPD
$320M
$237K 0.03%
4,454
-231
-5% -$11.6K
ICVT icon
296
iShares Convertible Bond ETF
ICVT
$7.73B
$235K 0.03%
2,605
IJR icon
297
iShares Core S&P Small-Cap ETF
IJR
$111B
$228K 0.03%
2,085
-8,066
-79% -$834K
TMO icon
298
Thermo Fisher Scientific
TMO
$234B
$222K 0.03%
548
-16
-3% -$6.69K
IBM icon
299
IBM
IBM
$217B
$219K 0.03%
+744
New +$192K
NZF icon
300
Nuveen Municipal Credit Income Fund
NZF
$2.4B
$218K 0.03%
18,248

Similar funds

James Investment Research's Q2 2025 Portfolio in Review

As of Q2 2025, James Investment Research held 352 positions worth $841M, up 6.8% from $788M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

James Investment Research's Q2 2025 filing shows 26 new, 57 increased, 124 reduced and 14 closed positions. Its largest new stake was Select STOXX Europe Aerospace & Defense ETF: 50,833 shares worth $2.19M. The largest sale was UnitedHealth, an estimated $6.32M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

  • James Investment Research's largest Q2 2025 buy was Select STOXX Europe Aerospace & Defense ETF: 50,833 shares worth $2.19M.
  • James Investment Research added most to iShares MSCI EAFE ETF in Q2 2025, an estimated $4.73M increase.
  • James Investment Research's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $6.32M.
  • James Investment Research fully exited Pfizer in Q2 2025, selling an estimated $693K.
  • James Investment Research's ten largest holdings make up 27% of its $841M portfolio in Q2 2025.
  • James Investment Research opened 26 new positions and closed 14 in Q2 2025.
  • James Investment Research's portfolio value rose 6.8% quarter-over-quarter to $841M.

Based on James Investment Research's 13F filing for Q2 2025, filed 1 Aug 2025.